Cardiac Manifestations of Hyperkalemia
Hyperkalemia produces a characteristic progression of electrocardiographic abnormalities that reflect increasingly dangerous cardiac conduction disturbances, beginning with peaked T waves and potentially culminating in ventricular fibrillation or asystole if untreated.
Progressive ECG Changes by Severity
The cardiac manifestations follow a predictable sequence as serum potassium rises 1:
Mild Hyperkalemia (5.5-6.5 mEq/L)
- Peaked T waves - tall, narrow-based, most prominent in precordial leads
- Shortened QT interval
- These are often the earliest and most commonly recognized findings 2, 1
Moderate Hyperkalemia (6.5-8.0 mEq/L)
- PR interval prolongation
- QRS complex widening
- P wave flattening or complete absence (atrial standstill)
- ST segment changes 3
Severe Hyperkalemia (>8.0 mEq/L)
- Fascicular and intraventricular blocks
- "Sine wave" pattern - a pre-terminal rhythm representing fusion of widened QRS with peaked T waves
- Ventricular fibrillation or asystole 4
Critical Clinical Considerations
Bradydysrhythmias Are Underrecognized
Hyperkalemia commonly produces bradycardic rhythms throughout the progression of ECG findings, but this manifestation is not well-taught and may be easily missed 4. This is particularly dangerous because:
- Standard bradycardia treatments (atropine, electrical pacing) are ineffective for hyperkalemia-induced bradycardia
- The diagnosis may be delayed until laboratory results return
- Clinical deterioration can be rapid without proper recognition
ECG Changes Are Not Always Present
A critical pitfall: abnormal ECG findings occur in only 61.5% of hyperkalemia cases, even with elevated potassium levels 5. This means:
- Normal ECG does not exclude dangerous hyperkalemia
- Patients with chronic kidney disease may show minimal or absent ECG changes despite significant hyperkalemia 5
- Clinical suspicion based on risk factors (renal disease, RAASi therapy, diabetes) must drive evaluation, not ECG alone
Underlying Cardiac Effects
Beyond ECG changes, hyperkalemia directly impairs 3:
- Cardiac contractility (reduced myocardial function)
- Automaticity (impaired pacemaker activity)
- Conductivity (slowed impulse transmission)
- Excitability (altered threshold for depolarization)
Risk Factors Requiring Heightened Vigilance
The guidelines emphasize that hyperkalemia risk is substantially elevated in patients with 6:
- Chronic kidney disease (up to 73% incidence in advanced CKD)
- Heart failure (up to 40% incidence)
- Diabetes mellitus
- RAASi therapy (ACE inhibitors, ARBs, MRAs, sacubitril/valsartan)
- Advanced age
Clinical Implications
Life-threatening arrhythmias may occur at variable thresholds between different patients 6. Potassium levels up to 6 mEq/L are often found without arrhythmia signs, especially in patients with chronic kidney disease, diabetes, or heart failure, where hyperkalemia is frequently discovered incidentally on routine blood tests 6.
The key is recognizing that ECG changes must be identified before clinical cardiovascular deterioration occurs to enable life-saving treatment and prevent irreversible fatal evolution 3.